Health and effects
Subjective sleep quality in cannabinoid studies
Subjective sleep quality is a self-reported outcome: how participants rate their sleep. It is different from measured sleep duration, sleep onset, awakenings, or sleep stages.
The short answer
What does the research say about Subjective sleep quality?
Researchers have studied cannabinoids in connection with Subjective sleep quality. The current literature covers CBD, THC, and CBN. This page brings together 3 human-study sources and 2 research reviews. It includes 7 specific study findings from 3 sources. Human research is included, although its design and scope vary. There is no single answer that applies to every cannabinoid, dose, product, or person. 1
Key takeaways
What to know first
- 1
Research on Subjective sleep quality covers CBD, THC, and CBN; those areas should not be combined into one claim. 1
- 2
Human research is included, although its design and scope vary. 2
- 3
Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3
Research areas
What researchers studied about Subjective sleep quality
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Human research included
CBD
Researchers have studied CBD in connection with Subjective sleep quality. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 2
Human research included
THC
Researchers have studied THC in connection with Subjective sleep quality. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 2
Human research included
CBN
Researchers have studied CBN in connection with Subjective sleep quality. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 3
Results extracted so far
What did the studies report?
These summaries appear only when the recorded study outcome is specific enough to reproduce from the linked source. If a source has no result summary here, the result has not been extracted yet; that does not mean the study found no effect.
-
In a systematic review and meta-analysis of randomized cannabinoid-versus-placebo studies involving 6 trials with 1,077 adults with or without insomnia or poor sleep, researchers did not detect a difference in pooled subjective sleep quality in cbd-only randomized trials following varied across included trials over varied across included trials. The recorded comparator was placebo. 1
Recorded result: CBD-only pooled effect SMD 0.13 (95% CI -0.38 to 0.65; P=.61), not statistically significant.
-
In a randomized placebo-controlled crossover pilot trial involving 20 adults with DSM-5 insomnia disorder, researchers reported a decrease in total sleep time after an acute THC-CBD dose following 10 mg THC and 200 mg CBD once by the oral route over single study night. The recorded comparator was placebo. 2
Recorded result: Total sleep time decreased by 24.5 minutes (P=.05; d=-.5).
-
In a randomized placebo-controlled crossover pilot trial involving 20 adults with DSM-5 insomnia disorder, researchers did not detect a difference in subjective sleep quality after an acute thc-cbd dose following 10 mg THC and 200 mg CBD once by the oral route over single study night. The recorded comparator was placebo. 2
Recorded result: No change in subjective sleep quality was detected.
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers did not detect a difference in wake after sleep onset following a single oral dose of 30 mg or 300 mg CBN. The recorded comparator was placebo. 3
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported shorter sleep onset latency following 300 mg CBN. The recorded comparator was placebo. 3
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported higher subjective sleep quality following 300 mg CBN. The recorded comparator was placebo. 3
-
In a randomized double-blind placebo-controlled crossover trial involving 20 adults with physician-diagnosed insomnia disorder, researchers reported more NREM-2 sleep following 300 mg CBN. The recorded comparator was placebo. 3
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
What these studies actually looked at
The research on Subjective sleep quality is not one kind of study. This source set includes 3 clinical studies in people and 2 systematic reviews or meta-analyses. 3
The recorded populations or models include people or patients (4 sources), 20 adults with DSM-5 insomnia disorder (1 source), and 20 adults with physician-diagnosed insomnia disorder (1 source). A result from one group or model should not be assumed to apply to another. 4
The most common recorded outcome focus is sleep-related outcomes (4 sources), subjective sleep quality (2 sources), and high-density EEG total sleep time (1 source). Closely related outcome names can still describe different measurements. 5
Some source records specify doses including 10 mg THC and 200 mg CBD once (1 source), 300 mg CBN (1 source), and single oral dose of 30 mg or 300 mg CBN (1 source). These are descriptions of what researchers tested, not personal dosing instructions. 1
The Subjective sleep quality source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 2
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
systematic review or meta-analysis
Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: A systematic review and meta-analysis of randomised studies.
On this page, this source examines CBD and sleep and CBD and pooled subjective sleep quality in CBD-only randomized trials. 1
- Study type
- systematic review or meta-analysis
- Population or model
- people or patients and 6 trials with 1,077 adults with or without insomnia or poor sleep
- Outcome focus
- sleep-related outcomes and pooled self-reported sleep quality
- Dose recorded
- varied across included trials
- Evidence stage
- evidence still limited and systematic review
clinical study in people
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial.
On this page, this source examines CBD and sleep, THC and sleep, and CBD and total sleep time after an acute THC-CBD dose and other related questions. 2
- Study type
- clinical study in people
- Population or model
- people or patients and 20 adults with DSM-5 insomnia disorder
- Outcome focus
- sleep-related outcomes and high-density EEG total sleep time and other recorded details
- Dose recorded
- 10 mg THC and 200 mg CBD once
- Evidence stage
- human research
clinical study in people
Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial
On this page, this source examines CBN and wake after sleep onset, CBN and sleep onset latency, and CBN and subjective sleep quality and other related questions. 3
- Study type
- clinical study in people
- Population or model
- 20 adults with physician-diagnosed insomnia disorder
- Outcome focus
- polysomnography wake after sleep onset and sleep onset latency and other recorded details
- Dose recorded
- single oral dose of 30 mg or 300 mg CBN and 300 mg CBN
- Evidence stage
- human research
systematic review or meta-analysis
Cannabis dosing and administration for sleep: a systematic review.
On this page, this source examines CBD and sleep and THC and sleep. 4
- Study type
- systematic review or meta-analysis
- Population or model
- people or patients
- Outcome focus
- sleep-related outcomes
- Evidence stage
- evidence still limited
clinical study in people
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial.
On this page, this source examines CBN and sleep. 5
- Study type
- clinical study in people
- Population or model
- people or patients
- Outcome focus
- sleep-related outcomes
- Evidence stage
- evidence still limited
Safety and limits
What should readers keep in mind?
Research on Subjective sleep quality should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
Can cannabinoids help with Subjective sleep quality?
Research exists, but there is not one answer for every cannabinoid or product. Human research is included, although its design and scope vary. 2
Why can studies reach different answers?
Studies may test different cannabinoids, doses, formulations, routes, people, and outcomes. Those differences can change the result. 3
What should I check in a study?
Check whether it studied people, what product and dose it used, what it measured, how long it lasted, and whether safety was reported. 4
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: A systematic review and meta-analysis of randomised studies. systematic review or meta-analysis; evidence still limited; systematic review PubMed 40929927 DOI 10.1016/j.smrv.2025.102156
-
2
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research PubMed 40631525 DOI 10.1111/jsr.70124
-
3
Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research PubMed 41698831 DOI 10.1111/jsr.70284
-
4
Cannabis dosing and administration for sleep: a systematic review. systematic review or meta-analysis; evidence still limited PubMed 36107800 DOI 10.1093/sleep/zsac218
-
5
Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. clinical study in people; evidence still limited PubMed 37612115 DOI 10.1136/bmjopen-2022-071148
See all 5 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Cannabinol for acute treatment of insomnia disorder in a randomized placebo-controlled crossover trial clinical study in people; human research / 4 linked research notes PubMed 41698831
- Cannabinol (CBN; 30 and 300 mg) effects on sleep and next-day function in insomnia disorder ('CUPID' study): protocol for a randomised, double-blind, placebo-controlled, cross-over, three-arm, proof-of-concept trial. clinical study in people; evidence still limited / 1 linked research note PubMed 37612115
- Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research / 4 linked research notes PubMed 40631525
- Effectiveness of cannabinoids on subjective sleep quality in people with and without insomnia or poor sleep: A systematic review and meta-analysis of randomised studies. systematic review or meta-analysis; evidence still limited; systematic review / 2 linked research notes PubMed 40929927
- Cannabis dosing and administration for sleep: a systematic review. systematic review or meta-analysis; evidence still limited / 2 linked research notes PubMed 36107800